Physician profile
Todd Dale Sekundiak
NPI 1780634568
$7,273,538.14
in general payments reported to CMS, 2019-2025
10 companies · $102K in 2025
The $102K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $953K · 2020: $770K · 2021: $996K · 2022: $773K · 2023: $3.6M · 2024: $72K · 2025: $102K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $3.5M · Education: $149K · Consulting Fee: $93K · Travel and Lodging: $24K · Food and Beverage: $9,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $3,506,341.04 |
| Education | $149,250.00 |
| Consulting Fee | $92,800.00 |
| Travel and Lodging | $24,468.52 |
| Food and Beverage | $9,228.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $7,258,735.24 | 2019-2025 | Persona, Oxford, G7 |
| Medtronic, INC. | $7,444.16 | 2021-2025 | Aquamantys(Tm), Plasmablade(Tm) |
| Medtronic USA, INC. | $6,524.83 | 2019-2020 | |
| Stryker Corporation | $287.29 | 2019-2021 | |
| Smith+Nephew, INC. | $271.82 | 2022-2025 | Pico, Pico 14 |
| Depuy Synthes Sales INC. | $117.32 | 2025 | |
| Globus Medical, INC. | $77.50 | 2023 | Excelsiusgps Robotic Navigation System |
| Onkos Surgical, INC. | $41.93 | 2025 | Eleos Limb Salvage System |
| Bayer Healthcare Pharmaceuticals INC. | $23.17 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $14.88 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Sekundiak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.